April 2025

Monthly Archives

Latest stories

More stories

  • Lecanemab AD Treatment: Low Eligibility Woes

    Alternative Medicines in Healthcare: What You Need to Know Alternative Medicines in Healthcare: What You Need to Know Alternative medicines have become increasingly popular in recent years as society becomes more health-conscious. With a growing demand for natural and holistic treatments, alternative medicines have emerged as a powerful force in the healthcare world. As an […] More

  • Celecoxib May Benefit a Subset of Patients With PIK3CA Mutations ASCO Post

    Study Finds Potential Personalized Approach to Colorectal Cancer Treatment Introduction Researchers have identified a potential breakthrough in personalized cancer treatment. According to a study published in the Journal of Clinical Oncology, administering the anti-inflammatory drug celecoxib after surgery may improve disease-free survival in a subset of patients with PIK3CA-mutated stage III colorectal cancer. Background After […] More

  • Maxx Royal Bodrum Resort unveils lavish 20-treatment-room spa in Türkiye

    Luxury Spa Launches in Türkiye at Maxx Royal Bodrum Resort Turkish hospitality group Maxx Royal Resorts has opened its new coastal retreat on Türkiye’s Bodrum peninsula, featuring a 4,500sq m destination spa. The Maxx Royal Bodrum Resort boasts 282 villas and suites designed by Turkish architect Mahmut Anlar. The resort’s flagship Maxx WellBeing Centre offers […] More

  • Century Therapeutics Aims to Revolutionize Cell Therapy with CNTY-101

    Alternative Medicines for Common Health Conditions Introduction Alternative medicines are becoming increasingly popular as people seek natural remedies for common health conditions. These treatments can include herbal supplements, acupuncture, meditation, and more. While alternative medicines are not a substitute for traditional medical care, they can complement it and promote overall well-being. In this article, we […] More

  • Vascular Changes in Brain Linked to Alzheimer’s Disease Uncovered by Researchers

    Uncovering the Molecular Signatures of Blood-Brain Barrier Dysfunction in Alzheimer’s Disease Alzheimer’s disease affects millions of people worldwide, and researchers have been tirelessly working to understand the mechanisms underlying this neurodegenerative disorder. One of the key findings in this area of study is the disruption of the blood-brain barrier, which plays a vital role in […] More

  • Ablation vs Pharmacological Treatment for Atrial Fibrillation Reduction

    Understanding GDPR: What You Need to Know On May 25, 2018, the General Data Protection Regulation (GDPR) officially went into effect. This regulation was designed to protect the personal data of individuals located within the European Union (EU), regardless of where the company collecting the data is based. As a result, organizations around the world […] More

  • Experience Safer Chemo for Advanced Pancreatic Cancer with XB2001 – OncLive

    XB2001 Treatment for Advanced Pancreatic Cancer Shows Promising Results in Reducing Adverse Effects Introduction XBiotech has recently announced promising findings in treating advanced pancreatic cancer using its experimental regimen, XB2001, in combination with chemotherapy. Reduced Adverse Effects and Improved Survival Rates The findings reveal that patients in the XB2001 arm experienced fewer adverse effects (297 […] More

  • Sarepta Therapeutics Expands US FDA Approval for ELEVIDYS in Duchenne!

    Sarepta Therapeutics Announces FDA Approval of ELEVIDYS Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, has announced the expansion of the ELEVIDYS label to include individuals with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are at least 4 years of age. The FDA granted traditional approval […] More

  • Pfizer’s PF-08046044: Will it Be Approved for Diffuse Large B-Cell Lymphoma?

    PF-08046044: A Promising Drug Candidate for the Treatment of Lymphomas PF-08046044, also known as SGN-35C, is a next-generation CD30-directed antibody conjugated with topoisomerase I inhibitor payload. It is currently in Phase I of clinical development by Pfizer for the treatment of lymphomas, including Hodgkin lymphoma (cHL), peripheral T cell lymphoma (PTCL), diffuse large B cell […] More

  • Why drugmakers are hesitant to invest in gene therapy for rare diseases and how this impacts families

    The Importance of Research in Healthcare and Alternative Medicines In recent years, the healthcare industry has seen immense growth and innovation in the field of research. With advancements in treatment options, diagnostic tools, and alternative medicines, patients have access to a wider range of healthcare interventions than ever before. In this article, we will explore […] More

Load More
Congratulations. You've reached the end of the internet.